Trial record 31 of 1423 for: Area Under Curve AND tablet
Pharmacokinetics Of Sildenafil Orally Disintegrating Tablet Formulation Given With Or Without Food.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01254396|
Recruitment Status : Completed
First Posted : December 6, 2010
Results First Posted : February 8, 2012
Last Update Posted : February 8, 2012
Information provided by (Responsible Party):
|Study Design||Allocation: Randomized; Intervention Model: Crossover Assignment; Masking: None (Open Label); Primary Purpose: Basic Science|
AUC (0-t) was the intended primary outcome measure.